News

OMA says policy represents a human rights ‘double jeopardy’

Big responses seen for right to not offer procedures due to religious beliefs and condemning deception ‘in patient’s best interest’

GlaxoSmithKline is introducing Infanrix hexa.

Bristol-Myers Squibb's Reyataz is now indicated for the treatment of HIV-1 infection in children six to 18 years of age.

B.C. reveals changes to pricing and reimbursement of new generics and a frequent-dispensing policy.

Alberta Health and Wellness Minister Ron Liepert announced details of the first phase of the province's major new pharmaceutical strategy on December 8.

Hearings start in the generic pharmaceutical industry's legal challenge of extended market monopolies for brand name drugs in the Federal Court of Canada.

Canada is the first country worldwide to approve Janssen-Ortho's Stelara for the treatment of psoriasis.